首页> 外文期刊>Egyptian Journal of Critical Care Medicine >Assessment of hypotension during dialysis as a manifestation of myocardial ischemia in patients with chronic renal failure
【24h】

Assessment of hypotension during dialysis as a manifestation of myocardial ischemia in patients with chronic renal failure

机译:评估慢性肾功能衰竭患者透析过程中低血压作为心肌缺血的表现

获取原文
       

摘要

Introduction Intradialytic hypotension (IDH) remains to be a major complication of hemodialysis occurring in nearly 25% of dialysis sessions. It is a significant independent factor affecting mortality in hemodialysis patients. Autonomic nervous system dysfunction, blood sequestration in the setting of hypovolemia, cardiovascular diseases and increased plasma level of end products of nitric oxide metabolism are possible causes. In this controlled prospective study we examined patients with chronic renal failure and intradialytic hypotension to evaluate the relationship between this hypotension and myocardial ischemia after controlling other possible causes. Materials and methods Thirty patients with chronic renal failure who are on regular dialysis were enrolled. Before dialysis, patients were subjected to history taking and clinical examination. Echocardiography and several lab tests were done. Glomerular filtration rate (GFR) was calculated using Cockcroft’s and Gault formula. Autonomic dysfunction was also assessed. The dialysis session was standardized in all patients. Intradialytic blood pressure was monitored and hypotension was classified as mild (SBP>100mmHg), moderate (SBP 80–100) or severe (SBP<80). After dialysis, myocardial ischemia was assessed using stress myocardial perfusion imaging (MPI) (Pharmacologic stress testing using Dipyridamole) and is further classified as mild, moderate or severe ischemia. Patients with sepsis, hemoglobin level less than 9g/dL, diabetes mellitus, low cardiac output, coronary artery disease, significant valvular lesion or body weight below the dry weight of the patient were excluded from the study. Bronchial asthma, emphysema and severe COPD are contraindications to Dipyridamole and thus were also excluded from the study. Results Twenty patients had no or mild intradialytic hypotension whereas ten patients had moderate or severe hypotension. Among the first group, only two patients (10%) were found to have myocardial ischemia, while in the latter group, seven patients (70%) had myocardial ischemia that’s mostly moderate ( p =0.002). Stress induced LV dysfunction was also significantly prevalent in patients with moderate or severe intradialytic hypotension as opposed to other group ( p =0.002) LVED. Conclusions Patients with CKD and regular hemodialysis who experience moderate or severe intradialytic hypotension have significantly higher prevalence of myocardial ischemia and stress induced myocardial dysfunction, than those who experience no or mild intradialytic hypotension.
机译:简介透析内低血压(IDH)仍然是近25%的透析过程中发生的血液透析的主要并发症。它是影响血液透析患者死亡率的重要独立因素。自主神经系统功能异常,血容量不足时的血液螯合,心血管疾病和一氧化氮代谢终产物血浆水平升高是可能的原因。在这项对照前瞻性研究中,我们检查了患有慢性肾功能衰竭和透析内低血压的患者,以评估控制其他可能原因后该低血压与心肌缺血之间的关系。材料和方法纳入30例接受定期透析的慢性肾功能衰竭患者。透析前,对患者进行病史采集和临床检查。进行了超声心动图检查和一些实验室检查。使用Cockcroft和Gault公式计算肾小球滤过率(GFR)。还评估了自主神经功能障碍。所有患者的透析过程均已标准化。监测透析内血压,将低血压分为轻度(SBP> 100mmHg),中度(SBP 80-100)或重度(SBP <80)。透析后,使用应激心肌灌注显像(MPI)(使用双嘧达莫进行药理学压力测试)评估心肌缺血,并进一步分为轻度,中度或重度缺血。败血症,血红蛋白水平低于9g / dL,糖尿病,心输出量低,冠状动脉疾病,明显的瓣膜病变或体重低于患者干重的患者被排除在研究范围之外。支气管哮喘,肺气肿和严重COPD是双嘧达莫的禁忌症,因此也被排除在研究之外。结果20例患者无或轻度透析内低血压,而10例患者有中度或重度低血压。在第一组中,只有2名患者(10%)被发现患有心肌缺血,而在第二组中,有7名患者(70%)具有心肌缺血,大部分是中度(p = 0.002)。与其他组(p = 0.002)LVED相比,在中度或重度透析内低血压患者中,压力诱发的LV功能障碍也很普遍。结论患有中度或重度透析内低血压的CKD和常规血液透析患者的心肌缺血患病率和应激性心肌功能障碍的发生率明显高于未经历或轻度透析内低血压的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号